Author: Danhauer SC, Tooze JA, Holder P, Miller C, Jesse MT.
Affiliation: Department of Internal Medicine, Section of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1082, USA. danhauer@wfubmc.edu
Conference/Journal: J Soc Integr Oncol.
Date published: 2008 Summer
Other:
Volume ID: 6 , Issue ID: 3 , Pages: 89-97 , Word Count: 199
BACKGROUND: Goals were to determine the feasibility of conducting a study of Healing Touch (HT) for acute leukemia patients and to obtain preliminary data on its effectiveness. METHODS: Forty hospitalized leukemia patients completed a brief survey of HT knowledge/experience. A prospective cohort (N = 12) was invited to participate in an HT intervention (9 30-minute sessions over 3 weeks); they completed measures of distress, symptoms, and sleep (at weeks 1 and 5), and completed single item ratings of fatigue, nausea, distress, and pain immediately pre-post selected HT sessions. The Wilcoxon signed rank test was used to analyze change in pre-post session ratings and distress, symptom, and sleep measures. RESULTS: Among survey respondents, 8% had used HT in the past, and 71% were interested in using HT. In the prospective cohort, there were significant pre-post session improvements in fatigue and nausea (but not in distress and pain). There were no significant changes between weeks 1 and 5 in distress, symptoms, or sleep. Ratings and qualitative feedback on HT were positive, focused mainly on feeling relaxed following HT sessions. CONCLUSIONS: It is feasible to recruit patients hospitalized for acute leukemia to a study of HT. Preliminary data on short-term improvements in symptoms indicate these are promising outcomes for future study.